blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1904447

EP1904447 - PIPERIDINE CARBOXAMIDE DERIVATE SUITABLE AS TACHYKININ RECEPTOR ANTAGONIST [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  05.03.2010
Database last updated on 08.06.2024
Most recent event   Tooltip05.03.2010Application deemed to be withdrawnpublished on 07.04.2010  [2010/14]
Applicant(s)For all designated states
GLAXO GROUP LIMITED
Glaxo Wellcome House, Berkeley Avenue Greenford
Middlesex UB6 0NN / GB
[2008/14]
Inventor(s)01 / MARTINUCCI, Silvia
GlaxoSmithKline, Via Alessandro Fleming 2
I-37135 Verona / IT
 [2008/14]
Representative(s)Dolton, Peter Irving Ernest
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[N/P]
Former [2008/14]Dolton, Peter Irving Ernest
GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road
Brentford, Middlesex TW8 9GS / GB
Application number, filing date06776300.314.07.2006
[2008/14]
WO2006EP07117
Priority number, dateGB2005001470718.07.2005         Original published format: GB 0514707
[2008/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007009778
Date:25.01.2007
Language:EN
[2007/04]
Type: A1 Application with search report 
No.:EP1904447
Date:02.04.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 25.01.2007 takes the place of the publication of the European patent application.
[2008/14]
Search report(s)International search report - published on:EP25.01.2007
ClassificationIPC:C07D211/58, A61K31/435, A61P25/00, A61P29/00
[2008/14]
CPC:
C07D211/58 (EP,US); A61P1/02 (EP); A61P1/04 (EP);
A61P1/08 (EP); A61P1/10 (EP); A61P1/14 (EP);
A61P1/16 (EP); A61P11/02 (EP); A61P11/04 (EP);
A61P11/16 (EP); A61P13/10 (EP); A61P15/00 (EP);
A61P17/00 (EP); A61P17/02 (EP); A61P17/04 (EP);
A61P17/06 (EP); A61P19/02 (EP); A61P19/04 (EP);
A61P19/06 (EP); A61P19/08 (EP); A61P25/00 (EP);
A61P25/02 (EP); A61P25/04 (EP); A61P25/06 (EP);
A61P25/18 (EP); A61P25/20 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P25/30 (EP);
A61P25/32 (EP); A61P25/34 (EP); A61P25/36 (EP);
A61P29/00 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P9/08 (EP); A61P9/10 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/14]
Extension statesRSNot yet paid
TitleGerman:ALS ANTAGONISTEN DES TACHYKININREZEPTORS GEEIGNETE PIPERIDINCARBONSÄUREAMIDDERIVATE[2008/14]
English:PIPERIDINE CARBOXAMIDE DERIVATE SUITABLE AS TACHYKININ RECEPTOR ANTAGONIST[2008/14]
French:DERIVE DE PIPERIDINE CARBOXAMIDE UTILE EN TANT QU'ANTAGONISTE DU RECEPTEUR DE LA TACHYKININE[2008/14]
Entry into regional phase15.01.2008National basic fee paid 
15.01.2008Designation fee(s) paid 
15.01.2008Examination fee paid 
Examination procedure15.01.2008Examination requested  [2008/14]
16.03.2009Despatch of a communication from the examining division (Time limit: M06)
29.09.2009Application deemed to be withdrawn, date of legal effect  [2010/14]
13.11.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/14]
Fees paidRenewal fee
10.07.2008Renewal fee patent year 03
08.07.2009Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DX]WO03099787  (TANABE SEIYAKU CO [JP], et al) [DX] 1-8 * p. 10, lines 10-15; page 207; compound 127 *;
 [DA]WO0232867  (GLAXO GROUP LTD [GB], et al) [DA] 1-8 * Compound (1a) *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.